Pancreatic ERCP

Like biliary endoscopy, pancreatic endoscopic retrograde pancreatography (ERCP) has evolved from being a diagnostic procedure to a therapeutic one. The advent of magnetic resonance cholangiopancreatography and endoscopic ultrasonography have limited the need for anatomic definition and transpapillary tissue sampling, respectively. This review is therefore limited to studies published during the past year concerned either with efforts to limit the incidence of post-ERCP pancreatitis or with critical reviews of therapeutic pancreatography, including the treatment of strictures, stones, and ductal disruption.

References

• 1 Rösch T, Daniel S, Scholz M. et al . Endoscopic treatment of chronic pancreatitis: a multicenter study of 1000 patients with long-term follow-up.  Endoscopy. 2002;  34 765-771
• 2 Kozarek R A. Endoscopic therapy of complete and partial pancreatic duct disruptions.  Gastrointest Endosc Clin N Am. 1998;  8 39-53
• 3 Venu R P, Brown R D, Marrero J A. et al . Endoscopic transpapillary drainage of pancreatic abscess: technique and results.  Gastrointest Endosc. 2000;  51 391-395
• 4 Seifert H, Wehrmann T, Schmitt T. et al . Retroperitoneal endoscopic debridement for infected peripancreatic necrosis.  Lancet. 2000;  356 653-655
• 5 Baron T H, Harewood G C, Morgan D E, Yates M R. Outcome differences after endoscopic drainage of pancreatic necrosis, acute pancreatic pseudocysts, and chronic pancreatic pseudocysts.  Gastrointest Endosc. 2002;  56 7-17
• 6 Andriulli A, Leandro G, Niro G. et al . Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis.  Gastrointest Endosc. 2000;  51 1-7
• 7 Murray B, Carter R, Imrie C. et al . Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography.  Gastroenterology. 2003;  124 1786-1791
• 8 Fazel A, Quadri A, Catalano M F. et al . Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study.  Gastrointest Endosc. 2003;  57 291-294
• 9 Mosler P, Sherman S, Marks J. et al . Oral allopurinol does not prevent the frequency or the severity of post-ERCP pancreatitis.  Gastrointest Endosc. 2005;  62 245-250
• 10 Katsinelos P, Kountouras J, Chatzis J. et al . High-dose allopurinol for prevention of post-ERCP pancreatitis: a prospective randomized double-blind controlled trial.  Gastrointest Endosc. 2005;  61 407-415
• 11 Andriulli A, Solmi L, Loperfido S. et al . Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate.  Clin Gastroenterol Hepatol. 2004;  2 713-718
• 12 Tsujino T, Komatsu Y, Isayama H. et al . Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial.  Clin Gastroenterol Hepatol. 2005;  3 376-383
• 13 Katsinelos P, Kountouras J, Paroutoglou G. et al . Intravenous N-acetylcysteine does not prevent post-ERCP pancreatitis.  Gastrointest Endosc. 2005;  62 105-111
• 14 Nathan T, Kjeldsen J, Schaffalitzky de Muckadell O B. Prediction of therapy in primary endoscopic retrograde cholangiopancreatography.  Endoscopy. 2004;  36 527-534
• 15 Rashdan A, Fogel E L, McHenry L Jr. et al . Improved stent characteristics for prophylaxis of post-ERCP pancreatitis.  Clin Gastroenterol Hepatol. 2004;  2 322-329
• 16 Sheehan S J, Lee J H, Wells C K, Topazian M. Serum amylase, pancreatic stents, and pancreatitis after sphincter of Oddi manometry.  Gastrointest Endosc. 2005;  62 260-265
• 17 Singh P, Das A, Isenberg G, Wong R C. et al . Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled trials.  Gastrointest Endosc. 2004;  60 544-550
• 18 Delhaye M, Arvanitakis M, Verset G. et al . Long-term clinical outcome after endoscopic pancreatic ductal drainage for patients with painful chronic pancreatitis.  Clin Gastroenterol Hepatol. 2004;  2 1096-1106
• 19 Delhaye M, Vandermeeren A, Baize M, Cremer M. Extracorporeal shock-wave lithotripsy of pancreatic calculi.  Gastroenterology. 1992;  102 610-620
• 20 Gabbrielli A, Pandolfi M, Mutignani M. et al . Efficacy of main pancreatic-duct endoscopic drainage in patients with chronic pancreatitis, continuous pain, and dilated duct.  Gastrointest Endosc. 2005;  61 576-581
• 21 Varadarajulu S, Noone T C, Tutuian R. et al . Predictors of outcome in pancreatic duct disruption managed by endoscopic transpapillary stent placement.  Gastrointest Endosc. 2005;  61 568-575
• 22 Soliani P, Franzini C, Ziegler S. et al . Pancreatic pseudocysts following acute pancreatitis: risk factors influencing therapeutic outcomes.  JOP. 2004;  5 338-347
• 23 Nealon W H, Walser E. Surgical management of complications associated with percutaneous and/or endoscopic management of pseudocyst of the pancreas.  Ann Surg. 2005;  241 948-957
• 24 Baillie J. Pancreatic pseudocysts (part I).  Gastrointest Endosc. 2004;  59 873-879
• 25 Baillie J. Pancreatic pseudocysts (part II).  Gastrointest Endosc. 2004;  60 105-113
• 26 Seewald S, Groth S, Omar S. et al . Aggressive endoscopic therapy for pancreatic necrosis and pancreatic abscess: a new safe and effective treatment algorithm (videos).  Gastrointest Endosc. 2005;  62 92-100
• 27 Kozarek R A. Endoscopic management of pancreatic necrosis: not for the uncommitted.  Gastrointest Endosc. 2005;  62 101-104
• 28 Cotton P B. Live endoscopy demonstrations are great, but….  Gastrointest Endosc. 2000;  51 627-629
• 29 Ramesh H. Live operative workshops: ethical issues.  Natl Med J India. 2004;  17 224-225
• 30 Axon A. Ethical considerations in gastroenterology and endoscopy.  Dig Dis. 2002;  20 220-225
• 31 Schmit A, Lazaraki G, Hittelet A. et al . Complications of endoscopic retrograde cholangiopancreatography during live endoscopy workshop demonstrations.  Endoscopy. 2005;  37 695-699